Current research into the role of engineered nanoparticles in drug delivery systems (DDSs)
for medical purposes has developed numerous fascinating nanocarriers. This paper reviews …

Albumin is an appealing carrier in nanomedicine because of its unique features. First, it is
the most abundant protein in plasma, endowing high biocompatibility, biodegradability …

In past decades, anticancer research has led to remarkable results despite many of the
approved drugs still being characterized by high systemic toxicity mainly due to the lack of …

Human serum albumin (HSA)-based therapeutics have attracted tremendous attention in the
development of anticancer agents. The versatile properties of HSA make HSA-based …

Erlotinib (ERT), oral administration agents, is one of the most pivotal targeted drugs in the
treatment of non‐small cell lung cancer (NSCLC); however, its poor solubility, low oral …

Abstract Background Brain metastases (BrM) incidence is 25% to 50% in women with
advanced human epidermal growth factor receptor 2 (HER2)‐positive breast cancer …

Currently, breast cancer (BRCA) has become the most common cancer in the world, whose
pathological mechanism is complex. Among its subtypes, triple-negative breast cancer …

Desmoplastic solid tumors are characterized by the rapid build‐up of extracellular matrix
(ECM) macromolecules, such as hyaluronic acid (HA). The resulting physiological barrier …

Breast cancer is one of the most widespread carcinoma and one of the main causes of
cancer-related death worldwide, especially in women aged between 35 and 75 years …

Albumin is a remarkable carrier protein with multiple cellular receptor and ligand binding
sites, which are able to bind and transport numerous endogenous and exogenous …